United States · Venture startup

Who invested in MedaSync

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Raised 3 months ago

Funding summaryUpdated 15 Nov 2026

$2.1Mraised across 2 rounds since 2025, from 2 sources

Latest round
Round, $2.1MAug 2026
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
?Venture$2.1MRound
First round
Venture
Aug 2025
Biggest round
$2.1M
Round · Aug 2026
Between rounds
13 months
from the last two

The rounds

  1. Aug 2026
    Round$2.1M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $2.1M sold, first sale Aug 2026

  2. Aug 2025
    VentureAmount undisclosed

    No investor was named in the report.

    Source recordedSEC filing: $1.6M sold, first sale Feb 2024

Funding filed with regulators

MedaSync filed 3 raises, $4.2M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Aug 2026$2.1M18 investorsSEC Form D
  2. Feb 2024$1.6M18 investorsSEC Form D
  3. Jul 2018$550K6 investorsdebt, otherof $750K offeredSEC Form D

Quick answers about MedaSync

How much has MedaSync raised?

MedaSync has raised $2.1M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.

When did MedaSync last raise?

MedaSync's most recent round, $2.1M, was in Aug 2026.

What was MedaSync's biggest round?

Its most recent round, $2.1M in Aug 2026, is also its largest on record.

What stage is MedaSync at?

MedaSync's latest named round is a Venture, in Aug 2025.

Where is MedaSync based?

MedaSync is based in the United States.

Companies like MedaSync

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.